news_image.jpg

New oral hormone drug for prostate cancer

22 Dec 2020



The Food and Drug Administration has approved the use of a new oral hormone therapy drug, Relugolix, for treating advanced prostate cancer in men.

Healio



Issue 50 - Winter 2020 - Addressing Childhood Obesity

Latest Newsletter

Issue 50 - Winter 2020 - Addressing Childhood Obesity

Issue 50 - Winter 2020 - Addressing Childhood Obesity

Newsletter Archive

Previous newsletters can be viewed and downloaded from the archive.

Newsletter Archive